Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Boiron (BOI.PA) has a market cap of $0.47 billion USD. According to our data, Boiron is ranked No.6048 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.47 B |
-10.82%
|
| Dec 31, 2024 | $0.53 B |
-30.77%
|
| Dec 29, 2023 | $0.76 B |
4.78%
|
| Dec 30, 2022 | $0.73 B |
44.95%
|
| Dec 31, 2021 | $0.50 B |
-11.45%
|
| Dec 31, 2020 | $0.56 B |
17.22%
|
| Dec 31, 2019 | $0.48 B |
-22.78%
|
| Dec 31, 2018 | $0.62 B |
-33.06%
|
| Dec 29, 2017 | $0.93 B |
-9.45%
|
| Dec 30, 2016 | $1.03 B |
15.24%
|
| Dec 30, 2015 | $0.89 B |
8.57%
|
| Dec 31, 2014 | $0.82 B |
38.52%
|
| Dec 31, 2013 | $0.59 B |
101.82%
|
| Dec 28, 2012 | $0.29 B |
33.89%
|
| Dec 30, 2011 | $0.22 B |
-28.65%
|
| Dec 30, 2010 | $0.31 B |
-1.21%
|
| Dec 31, 2009 | $0.31 B |
77.00%
|
| Dec 31, 2008 | $0.18 B |
-2.84%
|
| Dec 31, 2007 | $0.18 B |
1.79%
|
| Dec 29, 2006 | $0.18 B |
-13.78%
|
| Dec 30, 2005 | $0.21 B |
-9.45%
|
| Dec 31, 2004 | $0.23 B |
38.36%
|
| Dec 31, 2003 | $0.16 B |
-7.67%
|
| Dec 31, 2002 | $0.18 B |
19.77%
|
| Dec 31, 2001 | $0.15 B |
1.83%
|
| Dec 29, 2000 | $0.15 B |
23.38%
|
| Dec 31, 1999 | $0.12 B |
-7.19%
|
| Dec 31, 1998 | $0.13 B |
37.10%
|
| Dec 31, 1997 | $93.31 M |
31.49%
|
| Dec 31, 1996 | $70.96 M |
56.54%
|
| Dec 29, 1995 | $45.33 M |
33.79%
|
| Dec 30, 1994 | $33.88 M |
-4.20%
|
| Dec 31, 1993 | $35.37 M |
51.96%
|
| Dec 31, 1992 | $23.27 M |
81.56%
|
| Dec 31, 1991 | $12.82 M |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sanofi
SNY
|
$127.25 B |
3.672 B
|
France
|
 GlaxoSmithKline
GSK
|
$72.32 B |
0.003 M
|
UK
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Novartis
NVS
|
$218.28 B |
1.163 B
|
Switzerland
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$15.63 B |
35.904 M
|
Israel
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
Japan
|
| Market Cap | = | BOI.PA Stock Price | * | BOI.PA Shares Outstanding |
| = | $27.01 | * | 17.36 M | |
| = | $0.47 B |